Mechanical Ventilation and ARDS in the ED: A Multicenter, Observational, Prospective, Cross-sectional Study

Chest
Brian M FullerMarin H Kollef

Abstract

There are few data regarding mechanical ventilation and ARDS in the ED. This could be a vital arena for prevention and treatment. This study was a multicenter, observational, prospective, cohort study aimed at analyzing ventilation practices in the ED. The primary outcome was the incidence of ARDS after admission. Multivariable logistic regression was used to determine the predictors of ARDS. We analyzed 219 patients receiving mechanical ventilation to assess ED ventilation practices. Median tidal volume was 7.6 mL/kg predicted body weight (PBW) (interquartile range, 6.9-8.9), with a range of 4.3 to 12.2 mL/kg PBW. Lung-protective ventilation was used in 122 patients (55.7%). The incidence of ARDS after admission from the ED was 14.7%, with a mean onset of 2.3 days. Progression to ARDS was associated with higher illness severity and intubation in the prehospital environment or transferring facility. Of the 15 patients with ARDS in the ED (6.8%), lung-protective ventilation was used in seven (46.7%). Patients who progressed to ARDS experienced greater duration in organ failure and ICU length of stay and higher mortality. Lung-protective ventilation is infrequent in patients receiving mechanical ventilation in the ED, regardless ...Continue Reading

References

May 1, 1994·American Journal of Respiratory and Critical Care Medicine·J G MuscedereA S Slutsky
Oct 27, 1993·JAMA : the Journal of the American Medical Association·M H Kollef
Mar 1, 1997·The Journal of Clinical Investigation·L TremblayA S Slutsky
Feb 5, 1998·The New England Journal of Medicine·M B AmatoC R Carvalho
Feb 6, 1998·The American Journal of Emergency Medicine·M NelsonZ Randall
May 4, 2000·The New England Journal of Medicine·UNKNOWN Acute Respiratory Distress Syndrome NetworkArthur Wheeler
Feb 19, 2002·American Journal of Respiratory and Critical Care Medicine·Andrew D BerstenUNKNOWN Australian and New Zealand Intensive Care Society Clinical Trials Group
Mar 11, 2003·Critical Care Medicine·Jean-Louis VincentUNKNOWN Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) Study Group
Mar 29, 2003·Intensive Care Medicine·Mitchell M LevyUNKNOWN International Sepsis Definitions Conference
Apr 28, 2005·Annals of Emergency Medicine·K John McConnellRobert A Lowe
Sep 29, 2005·Annals of Emergency Medicine·Mark J SagarinUNKNOWN National Emergency Airway Registry Investigators
Oct 21, 2005·The New England Journal of Medicine·Gordon D RubenfeldLeonard D Hudson
Dec 24, 2005·Critical Care Medicine·Jeremy M KahnGordon D Rubenfeld
Feb 14, 2007·Chest·Gordon D Rubenfeld, Margaret S Herridge
Jun 19, 2007·Chest·Todd W RiceUNKNOWN National Institutes of Health, National Heart, Lung, and Blood Institute ARDS Network
Jun 22, 2007·Critical Care Medicine·Henry E WangDonald M Yealy
Jan 9, 2010·Critical Care : the Official Journal of the Critical Care Forum·Rogier M DetermannMarcus J Schultz
Mar 13, 2010·American Journal of Respiratory and Critical Care Medicine·Roger G SpraggAndrea L Harabin
Jun 3, 2010·JAMA : the Journal of the American Medical Association·J Hope KilgannonUNKNOWN Emergency Medicine Shock Research Network (EMShockNet) Investigators
Aug 31, 2010·American Journal of Respiratory and Critical Care Medicine·Ognjen GajicMichael Malinchoc
May 25, 2011·Circulation·J Hope KilgannonUNKNOWN Emergency Medicine Shock Research Network (EMShockNet) Investigators
Nov 22, 2011·The American Journal of Emergency Medicine·Benjamin D EasterJonathan Fisher
May 29, 2012·International Journal of Emergency Medicine·Peter C HouUNKNOWN US Critical Illness and Injury Trials Group: Lung Injury Prevention Study Investigators (USCIITG–LIPS 1)
Sep 18, 2012·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Munish GoyalDavid F Gaieski
Jan 22, 2013·Critical Care : the Official Journal of the Critical Care Forum·Brian M FullerChristopher R Carpenter
Apr 18, 2013·Critical Care Medicine·Andrew A HerringCarlos A Camargo
Jul 19, 2013·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Brian M FullerCraig McCammon
Aug 2, 2013·The New England Journal of Medicine·Emmanuel FutierUNKNOWN IMPROVE Study Group

❮ Previous
Next ❯

Citations

Oct 25, 2016·Annals of Emergency Medicine·Scott D Weingart
Mar 1, 2016·Journal of Educational Evaluation for Health Professions·Jeremy B RichardsSusan R Wilcox
Oct 4, 2016·Prehospital Emergency Care : Official Journal of the National Association of EMS Physicians and the National Association of State EMS Directors·Jeffrey SieglerHawnwan Philip Moy
Feb 6, 2017·International Journal of Emergency Medicine·Alexander BeyerBrian M Fuller
Jan 7, 2018·Emergency Medicine Journal : EMJ·David B PageBrian M Fuller
Jan 20, 2018·Critical Care : the Official Journal of the Critical Care Forum·David PageBrian M Fuller
Oct 12, 2018·Critical Care Medicine·Michael W SjodingTheodore J Iwashyna
Mar 13, 2017·Clinical Practice and Cases in Emergency Medicine·Matthew E Prekker, Stephen W Smith
Aug 24, 2019·Journal of Graduate Medical Education·Jonathan M KellerNitin Seam
Apr 12, 2020·The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association·Brad BoehringerNikiah G Nudell
May 10, 2016·Annals of the American Thoracic Society·Michael W SjodingTimothy P Hofer
Mar 7, 2020·The American Journal of Emergency Medicine·Tyler M FoleyNicholas M Mohr

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.